Earnings
Pfizer CEO Says Wall Street Is Wrong On Alrexvio: $600 Million For Pfizer, $5 Billion For A Rival
Albert Bourla told analysts the Street's long-range numbers diverge from Pfizer's own and expects them to adjust after the election.
PFE
Pfizer (PFE) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
SEC Filings
Pfizer Says A Federal 340B Pilot Will Reach Eliquis, Ibrance And Xtandi, Drugs Worth $4.1 Billion In A Quarter
Pfizer's quarterly report says the pilot, expected to start in January 2027, faces ongoing litigation; the company is still evaluating its impact.
Earnings
Pfizer Raises 2026 Revenue Forecast By $1.5 Billion At The Midpoint As Eliquis Jumps 25%
Third-quarter sales were flat at $16.6 billion as Eliquis and cancer drugs offset a 63% Paxlovid drop, and Pfizer named a new CFO.